On the positive side:
I trust our Board of Directors and I believe that they believe we have a fabulous product. There could be a minor element IMO, of a Board Member/Employee really appreciating their big salary, and thinking that it's a great income for now, eventhough the odds of becoming a "significantly profitable" company with 2 or more approvals, is only moderatlely favored at maybe 60/40, with a "possibility" of Cytodyn becoming a large and successful pharma company. I say more dilution is an absolute necessary move, as we are desperate, it is the smart move considering all the alternatives and the cash burn rate.
On the negative:
I do not trust our agencies to allow leronlimab to get to market, until we have a BP partner or buy-out. Knowing the history of leronlimab, combining that with histories of Phizer and Moderna and Novavax vaccines (I won't repeat the history) I am convinced 100% that.......
***our FDA is "corruptable"
***Phizer has huge controlling influence upon the FDA
***Phizer's vaccine is not just dangerous, it was known early-on to be very dangerous, the adverse side effects are numerous and frightening and this vaccine would never have been approved by a clean/honest FDA (did you hear the angry PhDs and MDs describing the known numerous Phizer side effects, a week ago at the live broadcasted 2 day discussion of vaccines?)
***Novavax's safe/superior vaccine was delayed by corruption
***Leronlimab's approval for critical cv19 was prevented by corruption
***2 1/2 years ago, Leronlimab should have been given EUA for Mild, Moderate and Critical CV19 patients, and would have prevented many many deaths and much suffering, physically/medically and economically, but deals were made with power players. Bruce Patterson was correct in April of 2020 at Ted Talks, he talked but they did not respond.
We'll see if another of my posts gets removed????
I trust our Board of Directors and I believe that they believe we have a fabulous product. There could be a minor element IMO, of a Board Member/Employee really appreciating their big salary, and thinking that it's a great income for now, eventhough the odds of becoming a "significantly profitable" company with 2 or more approvals, is only moderatlely favored at maybe 60/40, with a "possibility" of Cytodyn becoming a large and successful pharma company. I say more dilution is an absolute necessary move, as we are desperate, it is the smart move considering all the alternatives and the cash burn rate.
On the negative:
I do not trust our agencies to allow leronlimab to get to market, until we have a BP partner or buy-out. Knowing the history of leronlimab, combining that with histories of Phizer and Moderna and Novavax vaccines (I won't repeat the history) I am convinced 100% that.......
***our FDA is "corruptable"
***Phizer has huge controlling influence upon the FDA
***Phizer's vaccine is not just dangerous, it was known early-on to be very dangerous, the adverse side effects are numerous and frightening and this vaccine would never have been approved by a clean/honest FDA (did you hear the angry PhDs and MDs describing the known numerous Phizer side effects, a week ago at the live broadcasted 2 day discussion of vaccines?)
***Novavax's safe/superior vaccine was delayed by corruption
***Leronlimab's approval for critical cv19 was prevented by corruption
***2 1/2 years ago, Leronlimab should have been given EUA for Mild, Moderate and Critical CV19 patients, and would have prevented many many deaths and much suffering, physically/medically and economically, but deals were made with power players. Bruce Patterson was correct in April of 2020 at Ted Talks, he talked but they did not respond.
We'll see if another of my posts gets removed????
9
